Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

In short

This is a Research and Innovation Action under Horizon Europe. The budget is €44.2 million for about 6 grants of €6 million to €8 million each. Deadline for the first stage: 17 February 2027 (cut-off 2 of a series).

What the call wants to achieve

• Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases.
• Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases.
• Key stakeholders have access to trustworthy Artificial Intelligence (AI) tools to guide the development of multimodal predictive biomarkers of higher accuracy and clinical value when compared to the established practice.
• The citizens benefit of better health outcomes thanks to improved clinical guidelines and the implementation of effective biomarker-guided clinical research and personalised healthcare.

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0, summarised. The official call text and its annexes decide eligibility, budget and deadlines.

All cut-off dates

• 17 February 2027
• 16 September 2027

Similar calls